CB-03-01, also known as Clascoterone, is being developed as a solution for the treatment of male androgenic alopecia and is currently the most promising for FDA approval anti-hair loss hair growth drug. What is CB-03-01? CB-03-01 is the development code name for clascoterone, also known as Breezula. Clascoterone has already been approved by the FDA for the treatment of acne …